Mediclinic International plc
Mediclinic International plc (ANHGY) Stock Overview
Explore Mediclinic International plc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4B
P/E Ratio
N/A
EPS (TTM)
$0.23
ROE
N/A
ANHGY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mediclinic International plc (ANHGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $8.12.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.